Please provide your email address to receive an email when new articles are posted on . Results from a clinical trial examining intracranial stimulation using a novel device in those with mild ...
Can TMS reach the hippocampus? A new study demonstrates that personalized noninvasive brain stimulation can modulate deep ...
HOUSTON, TX, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NXL) (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) announces that its proprietary Deep Intracranial Frequency Stimulation ...
HOUSTON, TX, April 14, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NXL) (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results